The Endocrine Society advocates on behalf of our members, the patients they treat, and the science they research. Though our work in 2021 remained virtual, we successfully advocated for our policy priorities and raised the visibility of the value of endocrinology and endocrine research. Let’s look back at some of our wins from this year....
Failure to Reach Long-Term Budget Deal Disrupts Biomedical Research
Endocrine Society calls for $46.4 billion in NIH appropriations. Congress missed an opportunity to secure long-term funding for life-saving medical research in the midst of the pandemic. Congress averted a government shutdown by passing a two-month-long Continuing Resolution (CR), but it only provides temporary funding for the National Institutes of Health (NIH) and other government...
Endocrine Society Joins Rally for Medical Research Hill Day to Advocate for NIH Funding
On September 23, the Endocrine Society will join a group of scientific societies, academic institutions, and other biomedical research advocates as part of the 9th Annual Rally for Medical Research. Rally participants will call on the Congress to make funding for the National Institutes of Health (NIH) a national priority and raise awareness about the...
Grants Available for Early-Career Scientists Focusing on Type 1 Diabetes
Diabetes Research Connection announces grants ranging from $25,000 to $50,000 for early-career scientists focused on type 1 diabetes research from those seeing funding for research aimed at finding a cure, prevention, and treatments. Diabetes Research Connection (DRC), a 501(c)(3) that connects early-career scientists and donors to fund research projects aimed at prevention, cure, and better care...
Congress Considers Drug Pricing Legislation to Help Pay for Growing List of Legislation
Endocrine Society Continues to Advocate for Insulin Affordability Congressional leaders are continuing to discuss legislative options to address the rising cost of prescription drugs and the Endocrine Society continues to be one of the most vocal advocates urging Congress to address insulin affordability this year. The path forward for passing legislation to lower drug costs...
Endocrine Society Discusses ARPA-H with Congress, NIH, and OSTP
When President Joe Biden’s budget for fiscal year 2022 was introduced this summer, many biomedical research advocates took note of a new line item that would direct $6.5 billion over three years to a new Advanced Research Projects Agency for Health (ARPA-H) to be housed at the National Institutes of Health (NIH). While we were...
Endocrine Society Shares Information about Endocrine Research with Congressional Offices
The Endocrine Society has launched a series of educational briefings for congressional offices about endocrine research. On March 30, we hosted a virtual congressional briefing on COVID-19 and diabetes. Our panel included Congresswoman Kim Schrier (WA-08), the only U.S. Representative living with type 1 diabetes and a pediatrician; director of the National Institutes of...
Endocrine Society Members Advocate Virtually for Increased Federal Funding for Research
On March 16, the Endocrine Society conducted a “virtual” Research Hill Day where Endocrine Society members from across the U.S. met with their congressional representatives and their staff through Zoom, Skype, conference lines, and other electronic meeting platforms while the Capitol complex is closed for the pandemic and security reasons. During these meetings, Endocrine Society members urged Congress to provide an increase...
